Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Inc buy melinda

Start price
€75.06
05.09.18 / 50%
Target price
€83.89
05.09.18
Performance (%)
13.84%
End price
€85.45
05.09.18
Summary
This prediction ended on 05.09.18 with a price of €85.45. The BUY prediction by melinda finished with a performance of 13.84%. melinda has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
Tilray Inc -14.105% -14.105% -78.620% -
iShares Core DAX® 0.476% -0.039% 13.342% 17.330%
iShares Nasdaq 100 1.290% 0.504% 40.099% 50.534%
iShares Nikkei 225® 1.300% -2.135% 19.861% 4.937%
iShares S&P 500 0.829% 0.193% 29.756% 43.432%

According to melinda what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) 13.84%
Target price 83.886
Change
Ends at 05.09.18

SecteurProduits pharmaceutiques Agenda 06/09 | 13:30 Présentation



Métier
Logo Tilray Inc
Operates as holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.

Its products include dried cannabis and cannabis extracts.

The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Nombre d'employés : 245 personnes.



Prediction Buy
Perf. (%) 13.84%
Target price 83.886
Change
Ends at 05.09.18

(Zielkurs erreicht)

Stopped prediction by melinda for Tilray Inc

buy
Tilray Inc

Start price
Target price
Perf. (%)
€2.96
15.01.23
€3.50
15.01.24
-40.36%
16.01.24

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€4.14
15.11.22
€6.00
15.11.23
-28.55%
15.01.23

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€7.23
06.04.22
€10.00
06.04.23
-42.73%
15.11.22

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€18.50
26.03.21
€28.00
26.03.22
-57.95%
28.03.22

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€43.04
17.05.19
€83.89
04.11.21
-57.02%
26.03.21

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€115.92
27.09.18
€193.03
22.01.19
-43.40%
22.01.19

Could be worthwhile Investment >10% per year
Tilray Inc

Start price
Target price
Perf. (%)
€159.38
20.09.18
€135.30
25.09.18
-32.68%
25.09.18

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€109.72
13.09.18
€180.40
17.09.18
-2.82%
17.09.18

Could be worthwhile Investment >10% per year